The seemingly never-ending controversy over breast cancer screening guidelines has flared up again. On April 17, the American College of Physicians (ACP) published controversial new breast cancer screening guidelines, which reiterate the organization’s previous recommendation for biennial screening for women ages 50 to 74 and “informed decision making” with their physician for women ages 40 to 49 with their physician.
In a change, the ACP’s new guidelines say that supplemental digital breast tomosynthesis (DBT) should be considered in women with BI-RADS density category C or D, and that clinicians should not use supplemental MRI or ultrasound in asymptomatic women with average risk and with dense breasts (BI-RADS C or D).
The announcement immediately drew strong criticism from the American College of Radiology (ACR) and the Society of Breast Imaging (SBI). In a joint statement, the ACR and SBI said that the guidelines would lead to continued confusion and add more hardships among women.
In other top news this week, the U.S. Food and Drug Administration (FDA) denied a vendor petition to exempt certain types of AI software from the 510(k) clearance process.
Our coverage of the annual American Roentgen Ray Society (ARRS) meeting in Pittsburgh this week also attracted considerable interest among our members. Our current reporting of ARRS 2026 includes articles on how radiologists should embrace AI, a rebuttal over a claim that AI could replace radiologists, future workforce trends for emergency radiologists, and the effect of GLP-1 drugs on FDG-PET imaging scans.
We’re also pleased to welcome The PACSMan Pontificates to the AuntMinnie Podcast Network. Michael Cannavo, aka the PACSMan, has released the first episode in a new biweekly series that will feature his often irreverent takes on imaging informatics and AI.
See below for our other top stories from the week.
Erik L. Ridley
Editor in Chief
AuntMinnie.com
1. New ACP breast screening guidelines address supplemental imaging
2. ACR, SBI issue joint criticism toward ACP breast screening guidelines
3. FDA strikes down radiology AI 510(k) exemption arguments
4. ARRS president: Radiologists should embrace AI in evolving world
5. ARRS: Radiology chief fires back over claim AI could replace radiologists
6. ARRS: Emergency rads should brace for future workforce trends
7. ARRS: Do GLP-1 drugs confound FDG-PET imaging scans?
8. Podcast: The PACSMan Pontificates, Episode 1
9. Women’s Imaging MinnieCast, Episode 6 – What to know about BI-RADS v2025
10. FDG-PET predicts outcomes in metastatic breast cancer
11. ARRS: Ultrasound leads post-liver transplant monitoring
12. ARRS: AI does not improve efficiency, outcomes in PE care
13. MRI highlights worse muscle health from ultra-processed foods
Leave a Reply